Food, Beverage & Tobacco Healthcare Sector

STAAR Surgical

Market Cap: US$929.3m

Designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.

Collegium Pharmaceutical

Market Cap: US$926.3m

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

agilon health

Market Cap: US$910.7m

Provides healthcare services for seniors through primary care physicians in the communities of the United States.

Spyre Therapeutics

Market Cap: US$909.5m

A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD).

InMode

Market Cap: US$905.8m

Designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.

Nutex Health

Market Cap: US$900.9m

Operates as a physician-led, healthcare services, and operations company in the United States.

Pharvaris

Market Cap: US$893.1m

A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.

Nanosonics

Market Cap: AU$1.4b

Operates as an infection prevention company globally.

Extendicare

Market Cap: CA$1.2b

Through its subsidiaries, provides care and services for seniors in Canada.

Avadel Pharmaceuticals

Market Cap: US$859.0m

Operates as a biopharmaceutical company in the United States.

Bicara Therapeutics

Market Cap: US$854.0m

A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.

Evolent Health

Market Cap: US$852.7m

Through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.

HealthStream

Market Cap: US$849.2m

Provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States.

uniQure

Market Cap: US$833.8m

Develops treatments for patients suffering from rare and other devastating diseases in the United States.

CorMedix

Market Cap: US$831.5m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

AMN Healthcare Services

Market Cap: US$829.6m

Provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States.

Enliven Therapeutics

Market Cap: US$822.9m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.

Cronos Group

Market Cap: CA$1.1b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Niagen Bioscience

Market Cap: US$802.0m

Operates as a bioscience company engages in developing healthy aging products.

Zymeworks

Market Cap: US$800.0m

A clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID).

LENZ Therapeutics

Market Cap: US$794.3m

Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.

SI-BONE

Market Cap: US$785.0m

A medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.

Xeris Biopharma Holdings

Market Cap: US$781.6m

A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.

Praxis Precision Medicines

Market Cap: US$780.3m

A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.

Nuvation Bio

Market Cap: US$765.6m

A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.

Nurix Therapeutics

Market Cap: US$761.6m

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

WELL Health Technologies

Market Cap: CA$1.0b

Operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.

Veradigm

Market Cap: US$747.2m

A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.

Akebia Therapeutics

Market Cap: US$743.3m

A biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.

Immunome

Market Cap: US$736.1m

A clinical-stage biotechnology company, develops targeted cancer therapies.

Rocket Pharmaceuticals

Market Cap: US$706.8m

Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.

ArriVent BioPharma

Market Cap: US$705.8m

A clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.

GH Research

Market Cap: US$699.1m

Together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States.

Replimune Group

Market Cap: US$675.3m

A clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer.

Nika Pharmaceuticals

Market Cap: US$672.8m

A pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases.

Beta Bionics

Market Cap: US$672.5m

A commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes.